Enovix Corp (ENVX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Enovix Corporation on July 9, 2026. The filing discloses the appointment of a new Chief Operating Officer (COO) effective July 29, 2026.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change is the appointment of Dr. Michael Vyvoda as Chief Operating Officer. Dr. Vyvoda brings extensive operations experience from Magrathea Metals, Aircapture, and Apple Inc. (AirPods product line).
Compensation and Employment Terms
- Base Salary: $440,000 annually, commencing on the Effective Date.
- Annual Bonus: Discretionary cash bonus with a target of 60% of base salary, contingent on performance goals.
- Equity Grant (August 5, 2026):
- $4,000,000 in Restricted Stock Units (RSUs) vesting 25% after 12 months and the remainder quarterly thereafter.
- $100,000 in RSUs fully vested on the Grant Date.
- Severance: In the event of termination without Cause or resignation for Good Reason, Dr. Vyvoda is eligible for nine months of base salary, nine months of health care, a pro-rated bonus, and accelerated vesting of certain equity awards.
Outlook and Risks
The filing does not provide updated financial guidance, management commentary on market conditions, or specific risk factors beyond standard employment agreement terms. The full Employment Agreement will be filed as an exhibit to the next Form 10-Q.
Key Facts for Investor Verification
- Verify the effective start date of Dr. Vyvoda's role (July 29, 2026) and his prior operational track record at Magrathea Metals and Apple.
- Confirm the total equity value granted ($4.1 million) and the specific vesting schedule relative to the company's stock price on the grant date.
- Review the upcoming Form 10-Q for the full text of the Employment Agreement to understand specific definitions of "Cause," "Good Reason," and "Change of Control."
- Note that this filing contains no financial results; investors should refer to the most recent 10-Q or 10-K for financial health metrics.